Clinical trial
Clinical Validity of an AI-Based Biological Signal Analysis Software Vital-PICASO for Predicting the Risk of Cardiac Arrest Within 24hrs Using Vital Sign (SBP, DBP, HR, RR, BT, SpO2) From General Ward Inpatients; A Retrospective, Single-Center, Single-Arm, Superiority-Confirmatory Clinical Trial
NCT07742943 is registered in ClinicalTrials.gov with Huinno AIM as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Validity of an AI-Based Biological Signal Analysis Software Vital-PICASO for Predicting the Risk of Cardiac Arrest Within 24hrs Using Vital Sign (SBP, DBP, HR, RR, BT, SpO2) From General Ward Inpatients; A Retrospective, Single-Center, Single-Arm, Superiority-Confirmatory Clinical Trial
- Lead sponsor
- Huinno AIM
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 20, 2025
- Completion date
- December 19, 2025
- Enrollment
- 387 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.